ROIV Roivant Sciences Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: ROIV

Price (delayed)

$35.01

Market cap

$25.18B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.43

Enterprise value

$23.87B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 28
Highlights
The EPS has shrunk by 79% YoY but it has soared by 63% QoQ
The net income has dropped by 74% year-on-year but it has surged by 63% since the previous quarter
ROIV's gross profit has plunged by 75% YoY and by 43% from the previous quarter
Roivant Sciences's revenue has shrunk by 72% YoY and by 38% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ROIV

ROIV stock price

How has the Roivant Sciences stock price performed over time
Intraday
-0.26%
1 week
1.45%
1 month
2.94%
1 year
207.64%
YTD
61.34%
QTD
-1.07%

Financial performance

How have Roivant Sciences's revenue and profit performed over time
Revenue
$8.26M
Gross profit
$6.98M
Operating income
-$515.07M
Net income
-$299.77M
Gross margin
84.4%
Net margin
-3,629.2%
ROIV's operating margin has dropped by 81% year-on-year but it is up by 32% since the previous quarter
ROIV's gross profit has plunged by 75% YoY and by 43% from the previous quarter
The net income has dropped by 74% year-on-year but it has surged by 63% since the previous quarter
Roivant Sciences's revenue has shrunk by 72% YoY and by 38% QoQ

Price vs fundamentals

How does ROIV's price correlate with its fundamentals

Growth

What is Roivant Sciences's growth rate over time

Valuation

What is Roivant Sciences stock price valuation
ROIV P/E details
P/E
N/A
P/B
5.53
P/S
2,940.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,889.81
The EPS has shrunk by 79% YoY but it has soared by 63% QoQ
The stock's price to book (P/B) is 84% more than its last 4 quarters average of 3.0 and 68% more than its 5-year quarterly average of 3.3
ROIV's equity is up by 6% since the previous quarter but it is down by 3.4% year-on-year
The stock's price to sales (P/S) is 174% more than its last 4 quarters average of 1075.0
Roivant Sciences's revenue has shrunk by 72% YoY and by 38% QoQ

Efficiency

How efficient is Roivant Sciences business performance
The ROE has shrunk by 103% YoY but it has soared by 62% QoQ
ROIV's return on assets has dropped by 97% year-on-year but it has surged by 63% since the previous quarter
The ROIC has soared by 79% from the previous quarter and by 4.4% YoY
The ROS has soared by 63% QoQ

Dividends

What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ROIV.

Financial health

How did Roivant Sciences financials performed over time
ROIV's total liabilities has surged by 67% year-on-year and by 66% since the previous quarter
The company's quick ratio fell by 45% YoY and by 40% QoQ
The debt is 98% smaller than the equity
The debt to equity has declined by 33% since the previous quarter
The debt has increased by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.